Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daflon versus pentoxifylline for chronic venous insufficiency
IRCT20221213056808N1Phase 2Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of diosmin and pentoxifylline in venous stasis (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoints: Change in clinical symptoms, Change in Venous Clinical Severity Score and 5 more. Started Feb 2023; status: completed.
02
Drugs
diosminpentoxifylline
03
Conditions
venous stasis
Beyond the preview
Go deeper on IRCT20221213056808N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221213056808N1.